Clinical trial

Metabolic Mapping and Cardiac Resynchronization

NCT03420833

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-08-20

PhaseNA

Study timeline

Study start (actual)2018-08-20Date precision: day

Registry last updated2025-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Cardiac resynchronization therapy pacemaker (CRT-P)DEVICE

Sponsors & collaborators

Yong-Mei Chalead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Biotronik SE & Co. KGcollaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03420833 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.